StockWatch
·
HomeLiveReports

Genomic Valley Biotech Ltd

BSE: 539206

OverviewP/LShare Hold
values in crores

Revenue & Profit Trend

in crores
RevenueExpenditureNet Profit
-0.140.010.170.32Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27

Margin Trend

percentage
OPM %NPM %
-47.64-1.4344.7991.00Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
PeriodQ1 FY27Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q3 FY25Q2 FY25
INCOME
Revenue0.04+1.3%0.04-25.0%0.05-44.4%0.09+0.0%0.09-65.8%0.26+19.8%0.22+10.0%0.20
Other Income0.000.000.000.000.00-100.0%0.00—0.01
Total Income0.04+1.3%0.04-25.0%0.05-44.4%0.09+0.0%0.09-65.9%0.26+19.3%0.22+5.2%0.21
EXPENSES
Expenditure0.02-34.8%0.04-9.1%0.04-54.4%0.09+32.8%0.07-75.0%0.26+302.6%0.07-7.1%0.07
Tax0.00-100.0%0.010.000.000.00-100.0%0.09——
PROFIT
PBT0.01+812.5%0.00-84.8%0.01+218.2%0.00-86.6%0.02+1200.0%0.00-98.8%0.15+3.3%0.15
Net Profit0.01+280.2%-0.01-177.1%0.01+218.2%0.00-86.6%0.02+129.6%-0.08-153.8%0.15+3.3%0.15
KEY METRICS
OPM %40.53%+32.80pp7.73%-14.87pp22.60%+18.04pp4.56%-23.77pp28.33%+27.27pp1.06%—75.00%
NPM %38.42%+60.02pp-21.60%-42.60pp21.00%+17.33pp3.67%-23.77pp27.44%+59.08pp-31.64%-101.78pp70.14%-4.86pp75.00%
EPS0.05+66.7%0.03+0.0%0.03+200.0%0.01-87.5%0.08-70.4%0.27-47.1%0.51+920.0%0.05

Corporate Events

Board MeetingGVBL
2026
14Aug

Board Meeting

To consider and approve the unaudited financial results (sta…

BSE Filing ↗
Board MeetingGVBL
2026
29May

Board Meeting

To consider and approve the audited financial results (stand…

BSE Filing ↗
Board MeetingGVBL
2026
15Jan

Board Meeting

Considered and approved the standalone Un-audited financial …

BSE Filing ↗
Board MeetingGVBL
2024
7Oct

Board Meeting

consider and approve the unaudited financial results (standa…

BSE Filing ↗
Board MeetingGVBL
2024
29Jul

Board Meeting

considering and approving the unaudited financial results (s…

BSE Filing ↗
Board MeetingGVBL
2024
9May

Board Meeting

consider and approve audited financial results, quarter and …

BSE Filing ↗